Search

everythinglearnresearchcommunity

for

Search:↓

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

The study found that giant pandas have more melanin in black hair follicles than white, with gene expression differences that could affect hair color and skin health.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Patients with anxiety or depression report more severe alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Better models and evaluation methods for alopecia areata are needed.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

AA-PRP temporarily increases hair density in androgenetic alopecia but loses effectiveness over time.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

Trichoscopy is a reliable, non-invasive tool for diagnosing scalp alopecias.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Ladakh hotsprings contain compounds with potential medicinal benefits for various health conditions.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

Disease-specific tools better assess quality of life in alopecia areata patients.